Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- CLASSYS Inc.
- Study ID
- NCT07229430
- Status
- Recruiting
Conditions
- Facial Skin Laxity
- Skin Laxity (Submental and Neck)
- Submental Tissue Laxity
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- ULTRAFORMER MPT PLUS — DEVICEULTRAFORMER MPT PLUS (Classys Inc., Seoul, Korea) is a high-intensity focused ultrasound (HIFU) system that delivers focused energy at multiple depths to induce neocollagenesis and tissue contraction for non-surgical lifting and tightening of submental and neck tissue. The device includes both Default and MP modes and is under investigation under FDA IDE G250041.
- Ulthera System — DEVICEThe Ulthera System (Merz Aesthetics, USA) is an FDA-cleared high-intensity focused ultrasound (HIFU) device indicated for non-invasive lifting and tightening of lax tissue in the submental and neck areas. It serves as the active comparator for this non-inferiority clinical study.
Study Details
This is a prospective, multicenter, randomized, evaluator-blinded, parallel-controlled, non-inferiority clinical study designed to evaluate the safety and effectiveness of the ULTRAFORMER MPT PLUS, a high-intensity focused ultrasound (HIFU) device, for lifting and tightening lax submental (beneath the chin) and neck tissue in adult subjects. Approximately 273 subjects will be enrolled at multiple investigational sites across the United States. Participants will receive either the ULTRAFORMER MPT PLUS treatment or the predicate comparator device, and will be followed for safety and efficacy assessments including clinical photography, investigator evaluation, and patient-reported outcomes. The study aims to demonstrate that ULTRAFORMER MPT PLUS is non-inferior to the approved reference device in improving skin laxity and wrinkle appearance of the lower face and neck.
Key Dates
- Start date
- Oct 16, 2025
- Status verified
- Apr 2026
- Primary completion
- Nov 26, 2026
- Completion
- Nov 26, 2026
Study Design
- Enrollment
- 273 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ULTRAFORMER MPT PLUS GroupULTRAFORMER MPT PLUS (Classys Inc., Seoul, Korea) delivers high-intensity focused ultrasound (HIFU) energy to the subdermal tissue to induce neocollagenesis and tissue contraction for non-surgical skin tightening and lifting.
- Active Comparator: Ulthera Comparator GroupThe Ulthera® System (Merz Aesthetics, USA) uses focused ultrasound energy to lift and tighten submental and neck skin and serves as the reference comparator in this non-inferiority clinical trial.
Primary Outcome Measure
Submental Area Lift [Time Frame: 90 Days Post-Treatment] [ Time Frame: 90 Days Post-Treatment ]
Central Contacts
- Megan Kim+82-10-3723-4829
- James Lim
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dermatology | Los Angeles | California | 90004 | J, MD +1 (323) 464-8046 |
| Dermatology | Charlotte | North Carolina | 28405 | M, MD +1 (704) 375-6766 |
| Dermatology | Wilmington | North Carolina | 28405 | G, MD +1 (910) 256-4350 |
| Dermatology | Nashville | Tennessee | 37203 | B, MD +1 (615) 329-1110 |
| Dermatology | Spokane | Washington | 99204 | W, MD +1-509-343-3710 |